Finance

Lists
PNVL3:BVMF
Dimed SA Distribuidora de Medicamentos
11,00 BRL
0,00%
(0,00) 1D
16-ноя., 18:04:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for PNVL3...
Open
10,77 BRL
High
11,09 BRL
Low
10,76 BRL
Mkt. cap
1,65 млд
Avg. vol.
1,47 млн
Volume
640,70 миң
Dividend
3,62%
Quarterly dividend
0,10 BRL
Ex-dividend date
2014-ж., 30-апр.
P/E ratio
11,20
52-wk high
16,29 BRL
52-wk low
8,67 BRL
EPS
0,98 BRL
Shares outstanding
150,38 млн
No. of employees
12 миң
Open
10,77 BRL
High
11,09 BRL
Low
10,76 BRL
Mkt. cap
1,65 млд
Avg. vol.
1,47 млн
Volume
640,70 миң
Dividend
3,62%
Quarterly dividend
0,10 BRL
Ex-dividend date
2014-ж., 30-апр.
P/E ratio
11,20
52-wk high
16,29 BRL
52-wk low
8,67 BRL
EPS
0,98 BRL
Shares outstanding
150,38 млн
No. of employees
12 миң
News stories
From web sources and news partners
About Dimed SA Distribuidora de Medicamentos
CEO-
Employees11,6 миң
Founded1920
Headquarters-
SectorConsumer Staples
IndustryDrug
Last report
2026-ж., 6-ноя.
Fiscal period
Q3 2026
0,31 BRL / 0,32 BRL
-2,34%miss
Revenue / Est. (BRL)
1,57 млд / 1,68 млд
-6,53%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in BRL
Loading Previous Earnings...
Revenue
Net income
All values in BRL
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
1,57 млд
1,45 млд
1,51 млд
1,57 млд
Cost of goods sold
1,03 млд
895,86 млн
1,01 млд
1,06 млд
Cost of revenue
1,03 млд
895,86 млн
1,01 млд
1,06 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
447,70 млн
398,26 млн
434,04 млн
434,45 млн
Operating expense
460,93 млн
486,17 млн
438,84 млн
427,12 млн
Total operating expenses
1,49 млд
1,38 млд
1,45 млд
1,49 млд
Operating income
78,49 млн
67,63 млн
63,84 млн
82,82 млн
Other non operating income
-6,17 млн
-3,34 млн
-875,00 миң
8,18 млн
EBT including unusual items
46,89 млн
37,18 млн
35,36 млн
50,19 млн
EBT excluding unusual items
48,39 млн
36,64 млн
32,72 млн
50,19 млн
Income tax expense
4,14 млн
3,94 млн
4,99 млн
8,04 млн
Effective tax rate
8,83%
10,61%
14,11%
16,02%
Other operating expenses
13,23 млн
87,91 млн
4,79 млн
-7,33 млн
Net income
42,75 млн
33,23 млн
30,37 млн
42,15 млн
Net profit margin
2,73%
2,29%
2,01%
2,68%
Earnings per share
-
-
0,26
0,31
Interest and investment income
14,55 млн
12,28 млн
8,51 млн
-
Interest expense
-38,48 млн
-39,93 млн
-38,76 млн
-40,82 млн
Net interest expenses
-23,93 млн
-27,65 млн
-30,24 млн
-40,82 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
95,46 млн
84,75 млн
81,22 млн
235,90 млн
Gain or loss from assets sale
-
-2,92 млн
-
-
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору